Exploration and Establishment of an Early Warning System for Futile Reperfusion

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-01

Study Completion Date

2029-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this prospective cohort registration study is to establish an early warning system for futile recanalization in acute ischemic stroke by analyzing multi-omics information to identify key regulatory nodes and target molecules in ineffective recanalization.

The core issue addressed by this research is: Identifying key regulatory nodes and target molecules closely associated with futile recanalization, revealing the interactions among the neurovascular unit, peripheral immune cells, and the brain lymphatic system, as well as developing early diagnostic biomarkers and novel diagnostic technologies for futile recanalization.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy

NCT06361017

Acute Ischemic Stroke Endovascular Thrombectomy Dynamic Cerebral Autoregulation

ENROLLING_BY_INVITATION

Ischemic Strokes While on NOAC - How Compliance Matters

NCT04607070

Stroke, Ischemic Stroke, Acute Stroke Syndrome +3 more

RECRUITING

China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients

NCT02156765

Atrial Fibrillation Stroke

UNKNOWN

Early Neurological Trajectory and Clinical Outcomes in Brain Acute Ischemic Stroke

NCT06170086

Stroke, Acute

ACTIVE_NOT_RECRUITING

REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion

NCT05311605

Stroke Vascular Occlusion Endovascular Treatment +2 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Ischemic Stroke (AIS) Endovascular Thrombectomy Neurovascular Unit- Brain Lymphatic System

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Aged ≥18 years 2. Acute ischemic stroke confirmed by clinical and neuroimaging criteria (CT or MRI) 3. Clinical indication for thrombectomy 4. Provision of signed informed consent

Exclusion Criteria

* 1\. Preexisting dementia or severe disability (modified Rankin Scale score ≥3) 2. Cerebral vascular malformations, neoplasms, abscesses, or other significant non-ischemic brain pathologies 3. Life-limiting systemic comorbidities (e.g., end-stage organ failure, metastatic malignancies) with anticipated survival \<6 months 4. Patient or legally authorized representative declined consent 5. Anticipated poor protocol adherence or loss to follow-up

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No